Канал: Eurofins Discovery

Critical Importance of Early Safety Screening in Drug Development

Critical Importance of Early Safety Screening in Drug Development

Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation

Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation

Recent Trends in Kinase Drug Discovery

Recent Trends in Kinase Drug Discovery

SH2 Domains as a Target Class in Cancer and Inflammation

SH2 Domains as a Target Class in Cancer and Inflammation

Pharmacology Discovery Services - Capabilities Video

Pharmacology Discovery Services - Capabilities Video

Comprehensive Identification of Cardiovascular Safety Liabilities Using a Totality of Evidence

Comprehensive Identification of Cardiovascular Safety Liabilities Using a Totality of Evidence

Accelerating hit finding programs: Echo MS and RapidFire-MS key advantages

Accelerating hit finding programs: Echo MS and RapidFire-MS key advantages

Identify & Characterize New, Potent & Selective Ligands with E3scan Ligand-Binding Assay Technology

Identify & Characterize New, Potent & Selective Ligands with E3scan Ligand-Binding Assay Technology

Successful Hit Finding for PIM3 Kinase Inhibitors: From HTS to Extended Hit Characterization

Successful Hit Finding for PIM3 Kinase Inhibitors: From HTS to Extended Hit Characterization

Versatile Hit-Finding Strategies for Successful Drug Discovery Programs

Versatile Hit-Finding Strategies for Successful Drug Discovery Programs

Eurofins Discovery Lowers Barriers to Innovation in Research & Development Through Collaboration

Eurofins Discovery Lowers Barriers to Innovation in Research & Development Through Collaboration

Predicting Human Toxicities: A BioMAP® Platform Narrated Case Study

Predicting Human Toxicities: A BioMAP® Platform Narrated Case Study

Find your Next Novel Kinase Inhibitor with the KINOMEscan Technology

Find your Next Novel Kinase Inhibitor with the KINOMEscan Technology

Decoding Cancer and Inflammation: Identifying Selective Inhibitors of SH2 Domains

Decoding Cancer and Inflammation: Identifying Selective Inhibitors of SH2 Domains

Comprehensive In Vitro Approach to Evaluating Transporter-mediated Drug Interactions

Comprehensive In Vitro Approach to Evaluating Transporter-mediated Drug Interactions

Leveraging the E3scanTM technology platform for next-generation targeted protein degradation

Leveraging the E3scanTM technology platform for next-generation targeted protein degradation

Drug Discovery Trends & New Insights from Phenotypic Approaches

Drug Discovery Trends & New Insights from Phenotypic Approaches

Eurofins Discovery IDD Highlights

Eurofins Discovery IDD Highlights

An efficient and effective PIM3 kinase

An efficient and effective PIM3 kinase

In vitro NASH Panels and in vivo NASH models for NASH drug discovery

In vitro NASH Panels and in vivo NASH models for NASH drug discovery

Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)

Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS)

Eurofins Discovery Safety Pharmacology Portfolio

Eurofins Discovery Safety Pharmacology Portfolio

Eurofins Discovery: The Essence of our Entrepreneurial Spirit

Eurofins Discovery: The Essence of our Entrepreneurial Spirit

Eurofins Discovery: We Know What It Takes

Eurofins Discovery: We Know What It Takes

Eurofins Discovery: Big Enough to Deliver, Small Enough to Care

Eurofins Discovery: Big Enough to Deliver, Small Enough to Care

Eurofins Discovery: It All Starts with Biology

Eurofins Discovery: It All Starts with Biology

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 2

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 2

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 1

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 1

Oncology Drug Discovery & Early Lifestyle Solutions

Oncology Drug Discovery & Early Lifestyle Solutions

Get More Out of BioMAP®️ Early Screening Data with Tableau

Get More Out of BioMAP®️ Early Screening Data with Tableau

Global Anticancer Drug Discovery & Development Trends

Global Anticancer Drug Discovery & Development Trends

Nerve Injury Induced Neuropathic Pain Models in Rodents – Quick Video

Nerve Injury Induced Neuropathic Pain Models in Rodents – Quick Video

Hit Discovery for GPCRs: HTS or virtual screens?

Hit Discovery for GPCRs: HTS or virtual screens?

Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan Technology Platform

Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan Technology Platform

Eurofins Discovery 2021 SOT Annual Meeting and ToxExpo

Eurofins Discovery 2021 SOT Annual Meeting and ToxExpo

Eurofins Discovery | JSPS 2021 (Japanese Version) - 第12回日本安全性薬理研究会学術年会スポンサーセッション

Eurofins Discovery | JSPS 2021 (Japanese Version) - 第12回日本安全性薬理研究会学術年会スポンサーセッション

Eurofins Discovery | 2021 Japan Society for the Promotion of Science - 第12回日本安全性薬理研究会学術年会スポンサーセッション

Eurofins Discovery | 2021 Japan Society for the Promotion of Science - 第12回日本安全性薬理研究会学術年会スポンサーセッション

Small Molecule Inhibitors of Oncogenic SHP2 Variants Characterized by Cellular Target Engagement

Small Molecule Inhibitors of Oncogenic SHP2 Variants Characterized by Cellular Target Engagement

Eurofins Discovery Case Study: Understanding TPD Complexity using BioMAP® Human Phenotypic Platform

Eurofins Discovery Case Study: Understanding TPD Complexity using BioMAP® Human Phenotypic Platform

Eurofins Discovery - Drug Metabolism & Safety Services

Eurofins Discovery - Drug Metabolism & Safety Services

Challenges of Incorporating Non-Animal Preclinical Data into Drug Regulatory Applications

Challenges of Incorporating Non-Animal Preclinical Data into Drug Regulatory Applications

High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocyte

High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocyte

Challenges of Implementing Innovation in Drug Discovery and Development

Challenges of Implementing Innovation in Drug Discovery and Development

Using the BioMAP® Phenotypic Platform to Pivot and Reposition

Using the BioMAP® Phenotypic Platform to Pivot and Reposition

Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation

Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation

Eurofins Discovery BioMAP Services Overview

Eurofins Discovery BioMAP Services Overview

BioAsia Taiwan 2020

BioAsia Taiwan 2020

Phenotypic Services Center of Excellence

Phenotypic Services Center of Excellence

Pharmacology Discovery Services Taiwan Facility Grand Opening Ceremony

Pharmacology Discovery Services Taiwan Facility Grand Opening Ceremony

Validation of HTP assays using human iPSC-derived cardiomyocytes to assess cardiotoxic compounds

Validation of HTP assays using human iPSC-derived cardiomyocytes to assess cardiotoxic compounds

Reducing Attrition due to Drug-induced Liver Injury (DILI) Early in Drug Discovery

Reducing Attrition due to Drug-induced Liver Injury (DILI) Early in Drug Discovery

Eurofins Discovery Biomarker Services

Eurofins Discovery Biomarker Services

Eurofins Discovery Oncopanel

Eurofins Discovery Oncopanel

Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury Early in Drug Discovery

Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury Early in Drug Discovery

Reporter Assays for Therapeutics Targeting Signaling Pathways

Reporter Assays for Therapeutics Targeting Signaling Pathways

Online Ordering of MIC Assays - Pharmacology Discovery Services

Online Ordering of MIC Assays - Pharmacology Discovery Services

Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initative [2020 JSPS Seminar]

Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initative [2020 JSPS Seminar]

Toxicity Signature Analysis - Translational Insights with the Speed and Ease of in vitro Evaluation

Toxicity Signature Analysis - Translational Insights with the Speed and Ease of in vitro Evaluation

Eurofins Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initiative

Eurofins Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initiative

The Mast Cell Receptor MrgX2 and Drug-Induced Anaphylaxis. Eurofins Discovery - Drug Target Review

The Mast Cell Receptor MrgX2 and Drug-Induced Anaphylaxis. Eurofins Discovery - Drug Target Review

Implementing ADDC Assays in QC

Implementing ADDC Assays in QC

Eurofins Webinar: Preclinical Secondary Pharmacology Is an Essential Part of Drug Discovery

Eurofins Webinar: Preclinical Secondary Pharmacology Is an Essential Part of Drug Discovery

Establishing Qualified Bioassays for Checkpoint Receptors to Implement in QC Lot Release

Establishing Qualified Bioassays for Checkpoint Receptors to Implement in QC Lot Release

Eurofins Discovery: Chemical Probes in Disease Modeling Approaches

Eurofins Discovery: Chemical Probes in Disease Modeling Approaches

Eurofins Integrated Drug Discovery Webinar

Eurofins Integrated Drug Discovery Webinar

Eurofins Pharma Discovery Services

Eurofins Pharma Discovery Services

Recent Advances in Transporter Testing Strategies...

Recent Advances in Transporter Testing Strategies...

Eurofins Cerep-Panlabs: Epigenetic Webinar

Eurofins Cerep-Panlabs: Epigenetic Webinar

Eurofins Cerep-Panlabs: Toxicity Webinar

Eurofins Cerep-Panlabs: Toxicity Webinar

Eurofins Cerep-Panlabs: Oncology Webinar

Eurofins Cerep-Panlabs: Oncology Webinar

Eurofins Cerep-Panlabs: ADME-Tox Profiling in Drug Discovery

Eurofins Cerep-Panlabs: ADME-Tox Profiling in Drug Discovery

Eurofins Panlabs Safety Screening Webinar

Eurofins Panlabs Safety Screening Webinar

Eurofins Panlabs Anti-Infective Webinar 2013

Eurofins Panlabs Anti-Infective Webinar 2013

Eurofins Panlabs CNS Webinar

Eurofins Panlabs CNS Webinar

Eurofins Panlabs Oncology Webinar 2013

Eurofins Panlabs Oncology Webinar 2013